Browsing Centre for Immunobiology by Author "Yallis, YN"
Now showing items 1-1 of 1
-
Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?.
GILL, US; Zissimopoulos, A; Al-Shamma, S; Burke, K; McPhail, MJ; Barr, DA; Yallis, YN; Marley, RT; Kooner, P; Foster, GR (Oxford University Press, 2014-08-25)Abstract BACKGROUND: Tenofovir disoproxil fumarate (TDF) is an established nucleotide analogue in the treatment of chronic hepatitis B. Bone mineral density loss has been described in TDF-treated patients with human ...